Imed Infinity Medical-Limited Partnership Stock
Equities
IMED
IL0011712309
Investment Holding Companies
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
103.8 ILa | +1.17% | +3.49% | -9.11% |
Sales 2022 | 0.2 73.4 | Sales 2023 | -0.94 -345.7 | Capitalization | 1.28M 468M |
---|---|---|---|---|---|
Net income 2022 | -1M -367M | Net income 2023 | -1M -367M | EV / Sales 2022 | -2,846,670 x |
Net cash position 2022 | 2.21M 810M | Net cash position 2023 | 1.55M 568M | EV / Sales 2023 | 287,923 x |
P/E ratio 2022 |
-1.62
x | P/E ratio 2023 |
-0.72
x | Employees | 55 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | +1.17% | ||
1 week | +3.49% | ||
Current month | +34.81% | ||
1 month | +34.81% | ||
3 months | +50.00% | ||
6 months | +21.26% | ||
Current year | -9.11% |
Managers | Title | Age | Since |
---|---|---|---|
Itay Gal-Or
CEO | Chief Executive Officer | 40 | 22-11-20 |
Hanan Morris
DFI | Director of Finance/CFO | 58 | 20-09-28 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 21-08-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Suesskind
BRD | Director/Board Member | 80 | 21-08-14 |
Shuky Abramowitz
CHM | Chairman | 63 | 20-12-16 |
Yahel Shachar
BRD | Director/Board Member | 62 | 21-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 103.8 | +1.17% | 11,006 |
24-05-21 | 102.6 | +1.99% | 5,179 |
24-05-20 | 100.6 | +3.82% | 24,743 |
24-05-19 | 96.9 | -2.52% | 15,634 |
24-05-16 | 99.4 | -0.90% | 17,827 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 22, 2024 at 10:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-9.11% | 1.14M | |
+22.59% | 81.64B | |
+84.41% | 20.62B | |
+15.67% | 17.89B | |
+13.35% | 14.95B | |
+5.80% | 13.43B | |
+2.99% | 11.53B | |
+6.43% | 10.86B | |
+32.49% | 10.07B | |
-0.59% | 9.89B |
- Stock Market
- Equities
- IMED Stock